Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | T-cell metabolism: a novel therapeutic avenue for GvHD

Nataliya Buxbaum • 24 Apr 2022
The 2022 Tandem Meetings
General

Nataliya Buxbaum, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, talks on the important role of T-cells in graft-versus-host disease (GvHD). Recent experiments have shown that the T-cells mediating GvHD are glycolytic when entering target organs, which suggests metabolic therapy as a promising strategy to treat GvHD. In addition, this will enable imaging metabolic processes in vivo with MRI. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Nataliya Buxbaum

1:13
Towards personalized therapy for chronic GvHD
Nataliya Buxbaum • 24 Apr 2022
0:45
St. Jude Children's Research Hospital & Roswell Park’s efforts to help pediatric patients in Ukraine
Nataliya Buxbaum • 24 Apr 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals